TG Therapeutics Inc (TGTX)

NASDAQ · Biotechnology

51.07
+0.81 (+1.61%)
Updated Aug 19, 4:47 PM ET
AI Rating
Sell
Overall Score
39
Trend
39
Momentum
37
Risk
42

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 122 sessions Aug 18, 2026

AI Analysis

TG Therapeutics Inc is trading at $51.07, up 1.61% on the session. The 50 day average sits at $52.33 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 47.7, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $45.37 with resistance near $50.55, so that band frames the current range. Average daily movement is roughly $2.04, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 39 out of 100 combines a trend score of 39, momentum of 37 and a risk score of 42.

Technical indicators

RSI (14)
47.7
neutral
MACD
-0.971
bearish crossover
SMA 20
51.14
SMA 50
52.33
SMA 200
--
unknown
ATR (14)
2.04
avg daily range
Support
45.37
Resistance
50.55
Volume vs 20d
0.51x
below average
Volatility
57.5%
annualised
1 month
-6.86%
3 months
+27.31%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.